[April 29, 2016] |
|
WAVE Life Sciences to Present at the Deutsche Bank 41st Annual Health Care Conference
WAVE (News - Alert) Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company
focused on developing stereopure nucleic acid therapies for patients
with rare diseases, today announced that Paul Bolno, M.D., MBA,
President and Chief Executive Officer, will present at the Deutsche Bank
41st Annual Health Care Conference at 3:30 PM EDT on Wednesday, May 4,
2016 in Boston, Mass.
About WAVE Life Sciences At WAVE Life Sciences, we are
driven by an unwavering passion and commitment to deliver on our mission
of confronting challenging diseases by developing transformational
therapies and empowering patients to live the lives they choose. We are
utilizing our innovative and proprietary synthetic chemistry drug
development platform to design, develop and commercialize stereopure
nucleic acid therapeutics that precisely target the underlying cause of
rare and other serious genetically defined diseases. Give the
versatility of our chemistry platform, WAVE's deep, diverse pipeline
spans multiple modalities including antisense, exon-skipping, and
single-stranded RNAi. For more information, please visit www.wavelifesciences.com
and follow us on Twitter (News - Alert) at @WAVELifeSci
and LinkedIn.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160429006146/en/
[ Back To TMCnet.com's Homepage ]
|